12 studies found for:    lorcaserin [TREATMENT] AND obesity [DISEASE]
Show Display Options
Rank Status Study
1 Completed
Has Results
BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management
Condition: Obesity
Interventions: Drug: Lorcaserin 10 mg BID;   Drug: Matching Placebo BID
2 Completed
Has Results
BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management
Condition: Obesity
Interventions: Drug: Lorcaserin 10 mg QD;   Drug: Lorcaserin 10 mg BID;   Drug: Matching Placebo
3 Completed
Has Results
BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
Condition: Obesity
Interventions: Drug: Lorcaserin 10 mg QD;   Drug: Lorcaserin 10 mg BID;   Drug: Matching Placebo
4 Recruiting A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
Conditions: Cardiovascular Disease;   High Cardiovascular Risk;   Obesity;   Overweight;   Type 2 Diabetes
Interventions: Drug: APD356-Lorcaserin hydrochloride;   Drug: Placebo
5 Completed Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects
Condition: Obesity
Intervention: Drug: lorcaserin
6 Completed Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age
Condition: Pharmacokinetics in Obese Adolescents
Intervention: Drug: Lorcaserin
7 Completed To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake
Condition: Obesity
Interventions: Drug: Placebo;   Drug: Lorcaserin 10mg BID
8 Completed Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State
Condition: Obesity
Intervention: Drug: Lorcaserin 10mg
9 Completed Safety and Efficacy of APD356 in the Treatment of Obesity
Condition: Obesity
Intervention: Drug: APD356
10 Completed Safety and Efficacy of APD356 in the Treatment of Obesity
Condition: Obesity
Intervention: Drug: APD356
11 Recruiting Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management
Conditions: Overweight;   Obese
Interventions: Device: LLLT;   Drug: Lorcaserin
12 Active, not recruiting A Multicenter Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate- Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults
Condition: Chronic Weight Management
Interventions: Drug: lorcaserin;   Drug: phentermine-HCl;   Drug: phentermine placebo BID

Indicates status has not been verified in more than two years